Future Market Insights (FMI) predicts that the Protein A Resins Market Demand will surpass US$ 1.2 billion by 2031 at an 8.1% CAGR, based on a recent market analysis.
The market growth is driven by the development of biosimilar drugs and monoclonal antibody research. Monoclonal antibody research is advancing due to the global need for accurate and advanced biosimilars to reduce cancer risk.
Download a Sample Copy of report to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
The demand for protein A resins is high in contract manufacturing organisations (CMOs), according to FMI. Favorable research initiatives and funding in CMOs for monoclonal antibody production will drive market growth.
The sale of protein A resins has accelerated due to the COVID-19 outbreak and the increased development of monoclonal antibodies for virus treatment. Additionally, the demand for natural protein A resins has risen during FQ-20 for the purification of monoclonal antibodies, as they provide greater stability and reduce ligand leaching.
During the forecast period, the demand for natural protein A resins in biopharmaceutical manufacturing firms is expected to increase as they become more popular in advanced research.
FMI predicts that protein A resin sales for antibody purification will account for the majority of the market during the forecast period, as the rising prevalence of cancer and other chronic diseases has increased the demand for therapeutic monoclonal antibodies.
To maintain a competitive advantage in the industry, biopharmaceutical companies are actively seeking strategic alliances and mergers with other key players to launch new products and therapeutic drugs.
“Steered by increasing demand for biosimilar and monoclonal antibodies for therapeutic use, biopharmaceutical manufacturing companies are increasing investments in research and development activities to push biologics production. This is expected to create lucrative growth opportunities for market players,” says an FMI analyst.
Avail Discount on Report@ https://www.futuremarketinsights.com/request-discount/rep-gb-1720
Key Takeaways:
- The United States is expected to dominate the North American protein A resins market, accounting for more than 93.5% of the market.
- Because of the growing number of biopharmaceutical companies focusing on the development of biosimilar drugs, the United Kingdom will account for nearly 24.1% of the European market.
- Because of the increasing use of biomaterials in drug research, China is expected to grow at a 9.8% CAGR in East Asia. Sales of protein A resins in Japan are expected to grow at a 7.8% CAGR during the forecast period.
- In terms of matrix type, agarose-based matrix of protein A resins will account for more than 85.8% of the market in 2021.
- Biopharmaceutical manufacturers are expected to be the primary end-users in 2021, accounting for 79.2% of the market.
Prominent Drivers:
- Growing demand for therapeutic antibodies, as well as extensive research into monoclonal antibodies, will drive the market forward.
- The rising prevalence of cancer has prompted medical professionals to conduct extensive research into the development of monoclonal antibodies for therapeutic use. This is driving the market’s demand.
Key Restraints:
- The high cost of resins and a scarcity of skilled research analysts are expected to limit protein growth. A market for resins
Competitive Landscape
Key players are collaborating with end users and other regional players to strengthen their global presence. Some of the market players are focusing on product launches to capitalize on growing demand for monoclonal antibodies from biopharmaceutical companies. For instance:
- Purolite, a global manufacturer of resin-based chromatography separation, purification, and extraction technologies, will commercialise two novel next-generation chromatography resins in September 2021.
- Avantor Inc., a global provider of mission-critical products and services to life-sciences customers, announced PROchievA, a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAb production, in March 2020.
Request for Customized Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-1720
Leading players operating in protein A resins market profiled by FMI include:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
- Others
More Insights on FMI’s Protein A Resins Market
The latest market study on the protein A resins market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to offer a better perspective of the global protein A resins market, its growth trajectory, trends, and opportunities, the market is segmented on the basis of:
By Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
By Matrix:
- Agarose Based Matrix
- Glass or Silica Based Matrix
- Organic Polymer Based Matrix
By Application:
- Immunoprecipitation
- Antibody Purification
By End-User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
